Work

Abstract CT171: Cadonilimab in combination with lenvatinib and stereotactic body radiotherapy in potentially resectable hepatocellular carcinoma (UniRTX): A single-arm, phase II clinical trial

Cites:
Cited by: 1
Related to: 10